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Introduction  
The high and rising prevalence of chronic disease 
represents a substantial burden on the medical care 
system and a major cost for society, leaving aside its toll 
on individuals. Evidence comes from varied sources and 
is based on a range of methods. The burden is 
presented as rising rates of obesity,1 increased 
prevalence of diabetes,2 greater incidence of disability,3 
and the rising cost of medical care4 and other disease-
related costs.5 And, while the age-adjusted mortality 
from coronary heart disease and stroke has fallen, the 
aging of the population and rising obesity portend 
increases in both incidence and prevalence of 
cardiovascular disease in the near future.6 
 
The rise in obesity has been well documented in both 
the professional literature and the popular press. The 
Congressional Budget Office reports that medical 
spending on obese adults is 38 percent higher than on 
their normal-weight counterparts.7   Absenteeism has 
been shown to be higher among severely obese working 
women.8 Ormond and colleagues estimated the excess 
medical spending associated with uncomplicated 
diabetes and hypertension alone at $180 billion 
annually, with nearly three-quarters of this cost borne by 
private payers and individuals.9 The cost of 
cardiovascular disease in medical treatment and lost 
productivity has been estimated at $400 billion per year, 
of which about one-quarter comes from lost 
productivity.10 
 
There is widespread recognition that many of the most 
common chronic conditions could be largely prevented 
through changes in lifestyle-related behaviors such as 
reduced use of tobacco, improved diets, and increased 
physical activity.11  The results from the Diabetes 
Prevention Program (DPP) argue strongly for the 
efficacy of lifestyle change in preventing the 
progression of pre-diabetes to diabetes,12 and follow-
on studies support the sustainability of the health 
gains.13  Furthermore, recent studies have shown that 
the DPP protocol can be successfully implemented in a 
nonresearch setting at about one-tenth the cost of the 
original intervention.14  
 
The debate about whether the benefits of prevention 
outweigh its costs continues.15  The controversy stems 
in part from what is considered “prevention.” Recent 
research focusing specifically on workplace wellness 
programs, however, has found that every dollar 
invested in these programs can reduce medical care 
costs by $3.27 and costs associated with absenteeism 
by $2.73.16  Earlier research showed even greater 
returns using less strict criteria for study inclusion.17 
Goetzel and colleagues cite studies of programs at 
specific organizations, noting that most show positive 
financial returns but cautioning that program design 
and implementation are important components in 
successful programs.18   
 
Chronic disease has complex etiologies and treatment 
protocols, and estimating medical costs associated with 
particular diseases is methodologically tricky. The 
estimated costs seen in the literature represent a range 
that depends in part on what costs are included or 
excluded, how diseases are classified, and over what 
time period costs are calculated. Most estimates rely 
on national data, and extrapolations to smaller 
jurisdictions or entities are subject to adjustment for 
local factors such as the demographic makeup of the 
population, insurance coverage, and local medical 
practice patterns and costs.  
 
Despite these obstacles in quantifying the burden, the 
literature overwhelmingly supports the notion that the 
burden of chronic disease is large and growing. Often 
the costs are attributed broadly to society; some 
research is more specific, with medical costs assigned 
to different types of insurance. But there is little direct 
evidence available for the entities that might have the 
most to gain from reducing the costs imposed by 
chronic disease on the magnitude of their specific 
burden and the potential gains from reducing it. For 
example, state investments in prevention of chronic 
disease for their Medicaid populations may be offset by 
reduced Medicaid costs for care. Employers, both 
private and public, stand to gain from reduced medical 
care and health insurance costs and from reduced 
worker absenteeism and other improvements in 
efficiency associated with a healthier workforce.19 
 
From an employer’s perspective, the size of the burden 
associated with chronic disease represents the 
potential gain from reducing it and so gives an 
indication of how much it would be reasonable to invest 
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in prevention. Two factors influence the return on such 
investments: how effective prevention programs are in 
reducing chronic disease and how much such 
programs cost. The expansion of workplace wellness 
programs offers implicit evidence that many employers 
believe that prevention is a worthwhile investment. The 
state of Oregon has recently established a “Health 
Engagement” model for state employees.20  Pitney 
Bowes has a long-standing prevention and wellness 
program for its employees.21  America’s Health 
Insurance Plans has developed online wellness 
programs that subscribers can purchase.22  And 
entrepreneurs, such as Advancing Wellness,23 have 
begun offering programs for employers that prefer not 
to develop their own. The striking range of these efforts 
suggests that employers see a benefit in such 
programs.  
 
The California Public Employees' Retirement System 
(CalPERS) health program covers nearly 1.3 million 
active and retired state, local government, and school 
employees and their family members.24  It spent almost 
$7 billion in 2011 to purchase health benefits for the 
State of California (which can be considered a single 
employer) and for more than 1,100 local and 
government agency and school employers. The 
program offers three health maintenance organization 
(HMO) plans, three self-funded preferred provider 
organization (PPO) plans, and three plans for members 
of several employee associations.25   
 
Empirical Framework  
The analyses conducted for this report are designed to 
estimate the burden of preventable chronic disease on 
CalPERS State Active members and to describe the 
distribution of that burden by demographic 
characteristics, across geographic areas, across 
agencies and departments within state government, 
and across the health plans offered by CalPERS. State 
Active members are current California state employees 
and their dependents. 
 
To calculate these burdens, we estimate the per capita 
effect of two clusters of preventable chronic disease. 
With well-targeted interventions, the prevalence of 
Cluster I conditions—hypertension and type 2 diabetes 
without the presence of related comorbidities—has 
been shown to be modifiable in a relatively short period 
(one to two years).26   The second cluster, Cluster II, 
adds heart disease, stroke, and renal disease either 
alone or in combination with hypertension and 
diabetes. Because the risk of onset for the diseases in 
the second cluster is closely linked to the prevalence of 
the first cluster conditions, interventions targeted at 
Cluster I will likely have downstream effects on Cluster 
II. We assume these Cluster II effects can be expected 
in a slightly longer time horizon (five to ten years).  
Using regression analysis of the all payments made to 
providers by CalPERS on behalf of individual members 
over the full year, we calculate the fraction of those 
payments that are uniquely associated with each 
cluster of diagnoses. The resulting estimates give the 
fraction of these payments that would be eliminated in 
the absence of each cluster, holding constant all other 
factors, including other illnesses. These proportions 
can be interpreted as the share of expenditures that 
are amenable to reduction through proven prevention 
strategies targeting diet, exercise, and smoking 
behavior. 
 
Data  
Data for these analyses are derived from individual 
annual summary records of health care spending, 
demographics, and diagnoses for each State Active 
employee and his/her dependents covered by 
CalPERS between 2004 and 2008. The data exclude 
state retirees and their dependents, public agency 
active employees and their dependents, and public 
agency retirees and their dependents. 
 
Data on state employee race and ethnicity were 
provided by the California State Controller’s Office 
(SCO); no race/ethnicity data were available for 
dependents. To combine these records, Thomson 
Reuters (TR), the administrator of the CalPERS Health 
Care Decision Support System, generated a random 
identifier for each state employee and sent a finder file 
containing the random identifier and the employee’s 
Social Security number to SCO. SCO then added data 
on employee race/ethnicity and a salary range 
indicator, removed the Social Security number, and 
returned the file to TR, which matched the SCO 
records to the CalPERS records. In this way, no 
personal identifiers were provided to the research 
team. The resulting data files contained 2,691,551 
records. The large sample size results in highly precise 
estimates, as evidenced by the narrowness of the 
confidence intervals also shown in the table. 
 
Method 
The outcome variable was total CalPERS spending 
during the year paid to providers on behalf of the 
member. Ordinary least squares regression (OLS) was 
used to estimate the unique contribution of each 
explanatory factor in the model to total health 
spending. The key explanatory factors in the 
regression model were indicators for the Cluster I and 
Cluster II conditions. We also controlled for other 
factors that have been shown to contribute to variation 
in health spending. These include age; sex; 
employment tenure in four categories—< 1 year, 1–5 
years, 5–10 years, > 10 years; race/ethnicity in seven 
groups—American Indian, Asian, black, Filipino, 
Hispanic, non-Hispanic white, other, and missing.27   
To control for geographic differences in health care 
prices, we included 28 indicators for residing in each of 
the metropolitan statistical areas in the state. Finally, to 
control for changes over time in medical practice and 
prices, we included indicators for each year.  
 
We defined “excess expenditures” for a condition as 
CalPERS health expenditures on behalf of a member 
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with the condition beyond that predicted for someone 
without the condition but with other characteristics 
unchanged. The estimates for excess expenditures for 
each disease indicator in this model are shown in table 
1. For example, a person with diabetes (only) has 
estimated excess annual spending averaging $2,863 
more than someone with none of the target conditions. 
In the remaining tables, we label excess spending 
attributable to the Cluster I and Cluster II conditions as 
the “Preventable Costs.” 
 
The calculations presented in the rest of this report are 
made by multiplying these estimates by the number of 
members with the listed diagnoses in each subgroup 
(e.g., by age/sex, race/ethnicity, county, agency/
department, or health plan). 
 
Results 
Overall, our analysis finds that of the $1.6 billion spent 
by CalPERS in 2008 on the health care services used by 
its State Active members, $362 million (22.4%) was 
attributable to Cluster I and II chronic diseases that are 
amenable to prevention through changes in diet and 
physical activity. As a guide to targeting interventions to 
effect such changes, our analysis also pinpointed groups 
of members—identifiable by demographic 
characteristics, agency/department, county of residence, 
and health plan—with notably high or low shares of 
spending due to these conditions. 
 
Demographics 
Table 2 shows the total payments made by CalPERS 
and the portion of those payments that is attributable to 
the preventable conditions we include, by sex and age. 
One striking finding in this table is the much larger share 
of spending on preventable causes for males (27.9%) 
than for females (18.2%). While total CalPERS spending 
on females ($914 million) exceeds that on males ($702 
million), the difference in the share attributable to 
preventable chronic disease makes the amount of 
preventable costs larger among men ($195 million) than 
women ($166 million). The age pattern of this disparity 
suggests that part of this difference in shares is due to 
the portion of total spending on women that is due to 
childbirth. However, the share of male spending on 
preventable causes exceeds that of women in every age 
group except for children. The second pattern that 
emerges from this table is the increasing fraction of 
medical spending on preventable causes that is 
Table 1: CalPERS State Active Excess Expenditures  
(Per Person Per Year) of Selected Preventable Conditions 
Condition 
Annual  Excess  
Expenditure  
Per Person 
Cluster I   
Diabetes only $2,863 
Hypertension only $1,595 
Diabetes and Hypertension only $3,920 
Cluster II   
Diabetes with Heart, Cerebrovascular,  
or Renal Disease $21,181 
Hypertension with Heart, Cerebrovascular,  
or Renal Disease $14,576 
Diabetes, Hypertension, and Heart,  
Cerebrovascular, or Renal Disease $24,215 
Heart, Cerebrovascular, or Renal Disease  
without Diabetes or Hypertension $10,743 
Table 2. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by  Lifestyle Interventions,  
by Sex and Age, 2008 
Sex / Age 
Number of  
Persons  
Covered 
Average 
Spending per 
Person ($) 
Total CalPERS 
Payments 
($000) 
Share Attributable to  
Preventable Diseases 
Preventable 
Costs 
 ($000) Cluster Ia Cluster IIb Total 
Total 555,770     2,908 1,616,103 6.5% 15.9% 22.4% 362,047 
0–19 181,369     1,475 267,582 0.5% 4.6% 5.1% 13,565 
20–29 60,494     2,137 129,262 1.7% 7.2% 8.8% 11,417 
30–39 77,484     2,625 203,406 4.8% 10.4% 15.2% 30,913 
40–49 105,362     3,285 346,161 8.1% 15.9% 24.0% 83,168 
50–59 98,793     4,553 449,793 9.8% 20.7% 30.5% 137,121 
60–69 29,726     6,438 191,363 9.2% 29.5% 38.7% 74,007 
70 + 2,542     11,226 28,537 5.8% 35.7% 41.5% 11,856 
Female 285,226     3,205 914,013 5.3% 13.0% 18.2% 166,462 
0–19 88,693     1,532 135,845 0.4% 4.4% 4.9% 6,622 
20–29 31,274     2,807 87,786 1.2% 6.5% 7.7% 6,742 
30–39 42,063     3,425 144,065 3.1% 8.9% 12.0% 17,262 
40–49 56,637     3,825 216,634 5.9% 13.4% 19.3% 41,906 
50–59 52,209     4,604 240,347 8.7% 17.9% 26.6% 63,909 
60–69 13,501     5,999 80,998 9.4% 24.1% 33.4% 27,065 
70 + 849     9,821 8,338 7.1% 28.4% 35.5% 2,956 
Male 270,543     2,595 702,090 8.0% 19.9% 27.9% 195,585 
0–19 92,676     1,421 131,737 0.5% 4.8% 5.3% 6,943 
20–29 29,220     1,419 41,476 2.7% 8.6% 11.3% 4,675 
30–39 35,421     1,675 59,341 8.8% 14.2% 23.0% 13,651 
40–49 48,725     2,658 129,527 11.8% 20.1% 31.9% 41,262 
50–59 46,584     4,496 209,446 10.9% 24.0% 35.0% 73,212 
60–69 16,225     6,802 110,365 9.1% 33.4% 42.5% 46,943 
70 + 1,692     11,938 20,199 5.3% 38.8% 44.1% 8,900 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
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associated with age. Where “preventable” spending by 
women and men in their 30s is 12.0 and 23.0 percent of 
total spending, respectively, the shares for those in their 
60s are 33.4 and 42.5 percent, respectively. 
 
Table 3 shows the same calculations by race and 
ethnicity. The groups with the highest shares of 
spending that is attributable to preventable causes are 
Filipinos (38.5%) and Asians (34.2%), and the groups 
with the lowest such shares are non-Hispanic whites 
(26.4%) and Pacific Islanders (26.7%). However, the 
largest portion of preventable expenditures ($113 
million) was spent on behalf of non-Hispanic white 
employees because of their greater representation in the 
state workforce. 
Geography 
A second set of analyses examined geographic 
differences in expenditures on the included preventable 
illnesses. Table 4 displays these calculations by county 
of residence of CalPERS members. Figure 1 displays 
the total share of expenditures attributable to Cluster I 
and II diseases.  
 
The counties with the highest total spending on these 
conditions were Sacramento ($63.7 million), Los 
Angeles ($43.8 million), San Bernardino ($19.7 million), 
Orange ($16.7 million), and San Diego ($16.1 million), 
where there are the largest numbers of CalPERS 
members. The share of all expenditures that are  
Table 3. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
by Race and Ethnicity, 2008 (Employees Only) 
Race / Ethnicity 
Number of 
Persons 
Covered 
Average 
Spending per 
Person ($) 
Total 
CalPERS Pay-
ments ($000) 
Share Attributable to  
Preventable Diseases 
Preventable 
Costs 
($000) Cluster Ia Cluster IIb Total 
Total 224,465    3,500 785,635 8.9% 19.5% 28.4% 222,851 
Native American 1016    3,773 3,833 9.3% 20.3% 29.6% 1,136 
Asian 19,379    2,612 50,625 10.7% 23.5% 34.2% 17,304 
African American 23,285    3,700 86,149 11.1% 18.3% 29.3% 25,283 
Filipino 9,790    3,020 29,566 15.8% 22.7% 38.5% 11,379 
Latino 45,249    2,928 132,471 11.7% 18.4% 30.1% 39,908 
Pacific Islander 629    4,340 2,730 10.6% 16.2% 26.7% 730 
Non-Hispanic White 110,639    3,867 427,797 7.2% 19.2% 26.4% 112,967 
Other 5,732    3,457 19,814 8.0% 19.5% 27.5% 5,448 
Unknown 8,746    3,733 32,651 6.2% 20.4% 26.6% 8,696 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
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Table 4. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
by County of Residence, 2008 
County 
Number of  
Persons  
Covered 
Average 
Spending per 
Person ($) 
Total CalPERS 
Payments 
($000) 
Share Attributable to  
Preventable Diseases 
Preventable 
Costs 
($000) Cluster Ia Cluster IIb Total 
Total 555,770 2,908 1,616,103 6.5% 15.9% 22.4% 362,047 
Alameda 13,967 3,388 47,321 6.0% 13.9% 19.9% 9,415 
Alpine 44 2,538 112 * * * * 
Amador 2,286 2,985 6,824 5.9% 13.6% 19.5% 1,330 
Butte 6,385 3,110 19,860 6.4% 18.6% 25.0% 4,958 
Calaveras 1,284 3,638 4,672 5.5% 16.3% 21.8% 1,018 
Colusa 221 4,267 943 * * * * 
Contra Costa 9,119 3,228 29,434 5.9% 14.0% 19.9% 5,866 
Del Norte 3,394 3,693 12,535 5.2% 14.9% 20.1% 2,520 
El Dorado 6,939 3,214 22,301 5.0% 12.8% 17.8% 3,959 
Fresno 22,113 2,524 55,813 7.3% 19.6% 26.9% 15,011 
Glenn 335 4,159 1,393 4.9% 18.7% 23.6% 329 
Humboldt 4,530 2,653 12,017 7.2% 15.1% 22.3% 2,681 
Imperial 7,893 1,976 15,599 10.5% 19.9% 30.4% 4,743 
Inyo 692 3,865 2,674 6.5% 11.7% 18.3% 489 
Kern 22,052 2,174 47,940 8.5% 21.2% 29.7% 14,219 
Kings 8,433 2,508 21,149 8.6% 19.4% 28.1% 5,937 
Lake 693 3,209 2,224 5.4% 17.7% 23.1% 514 
Lassen 6,002 2,793 16,766 4.8% 12.9% 17.8% 2,982 
Los Angeles 59,104 2,406 142,223 9.0% 21.9% 30.8% 43,841 
Madera 4,062 2,418 9,824 7.7% 23.8% 31.5% 3,090 
Marin 1,941 3,563 6,915 3.2% 15.4% 18.6% 1,289 
Mariposa 466 2,561 1,193 4.1% 15.3% 19.4% 232 
Mendocino 1,018 3,368 3,429 5.8% 12.5% 18.3% 627 
Merced 2,842 2,914 8,282 7.6% 22.4% 30.0% 2,484 
Modoc 270 1,920 518 * * * * 
Mono 193 3,909 754 * * * * 
Monterey 7,867 4,054 31,896 6.8% 12.9% 19.7% 6,298 
Napa 3,809 3,273 12,466 4.9% 12.6% 17.6% 2,194 
Nevada 1,374 3,135 4,307 5.9% 13.0% 18.9% 815 
Orange 20,409 2,786 56,855 8.0% 21.4% 29.4% 16,728 
Placer 12,972 3,826 49,629 3.2% 11.0% 14.2% 7,050 
Plumas 398 3,055 1,216 4.0% 22.1% 26.1% 317 
Riverside 25,266 2,457 62,071 7.1% 15.6% 22.7% 14,097 
Sacramento 112,369 3,350 376,450 4.9% 12.0% 16.9% 63,715 
San Benito 473 3,352 1,585 5.0% 12.0% 17.0% 269 
San Bernardino 31,560 2,348 74,109 8.4% 18.2% 26.6% 19,730 
San Diego 25,020 2,641 66,074 6.8% 17.6% 24.4% 16,147 
San Francisco 7,064 2,912 20,570 6.6% 15.8% 22.4% 4,608 
San Joaquin 10,207 2,955 30,160 7.3% 19.1% 26.4% 7,950 
San Luis Obispo 16,886 2,905 49,052 6.7% 17.8% 24.5% 12,025 
San Mateo 4,844 3,235 15,669 7.5% 15.1% 22.6% 3,544 
Santa Barbara 2,366 3,252 7,694 6.4% 14.4% 20.8% 1,602 
Santa Clara 9,508 3,465 32,947 6.1% 13.8% 19.9% 6,559 
Santa Cruz 1,772 3,493 6,190 4.6% 15.9% 20.5% 1,268 
Shasta 4,312 2,342 10,100 7.5% 18.6% 26.0% 2,628 
Sierra 77 4,130 318 * * * * 
Siskiyou 1,073 3,121 3,348 3.7% 11.4% 15.2% 509 
Solano 14,477 3,184 46,089 6.2% 11.1% 17.3% 7,958 
Sonoma 7,955 3,311 26,336 5.0% 15.3% 20.2% 5,327 
Stanislaus 5,355 2,790 14,940 5.6% 17.3% 22.9% 3,417 
Sutter 2,389 3,183 7,603 5.7% 24.3% 29.9% 2,276 
Tehama 927 3,015 2,795 6.2% 12.0% 18.2% 509 
Trinity 236 1,608 380 * * * * 
Tulare 15,099 2,556 38,591 7.9% 22.6% 30.4% 11,749 
Tuolumne 1,862 3,003 5,591 5.2% 14.7% 19.9% 1,114 
Ventura 6,238 2,856 17,815 7.9% 17.8% 25.7% 4,576 
Yolo 9,739 3,531 34,392 4.2% 11.7% 15.9% 5,475 
Yuba 1,633 3,532 5,768 4.6% 10.6% 15.2% 879 
Other Place (incl. other states) 3,963 2,620 10,383 7.6% 18.0% 25.6% 2,656 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
* Due to potentially unreliable estimates, we exclude counties with less than $1,000,000 total CalPERS payments from these calculations. 
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Table 5a. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
for Largest Departments and Agencies, for Employees and Dependents, 2008 
Department / Agency 
Number of 
Persons 
Covered 
Average 
Spending 
per Person 
($) 
Total 
CalPERS 
Payments 
($000) 
Share Attributable to  
Preventable Diseases Preventable Costs 
($000) Cluster Ia Cluster IIb Total 
Total 555,777  2,908 1,616,103 6.5% 15.9% 22.4% 362,047 
Board of Equalization 7,435  2,805 20,857 6.7% 13.6% 20.3% 4,238 
California State University System 75,899  2,727 206,939 6.7% 19.4% 26.1% 54,069 
Dept of California Highway Patrol 30,039  2,552 76,656 4.2% 12.2% 16.4% 12,574 
Dept of Corrections 139,811  2,628 367,420 6.8% 15.7% 22.6% 82,950 
Dept of Developmental Services 11,267  3,226 36,351 7.8% 19.5% 27.3% 9,909 
Dept of Forestry and Fire Protection 15,074  2,290 34,525 4.7% 12.0% 16.7% 5,749 
Dept of General Services 6,365  2,934 18,674 6.5% 16.6% 23.1% 4,318 
Dept of Health Care Services 5,438  3,571 19,417 6.3% 16.9% 23.2% 4,511 
Dept of Justice 9,491  3,160 29,996 5.1% 14.0% 19.1% 5,721 
Dept of Mental Health 20,897  3,004 62,779 7.8% 17.8% 25.5% 16,030 
Dept of Motor Vehicles 17,055  3,157 53,846 7.5% 15.1% 22.6% 12,164 
Dept of Public Health 5,524  3,697 20,422 5.7% 15.1% 20.8% 4,247 
Dept of Social Services 7,355  3,460 25,445 6.5% 14.7% 21.1% 5,382 
Dept of Transportation 49,392  2,881 142,290 7.1% 16.6% 23.7% 33,743 
Dept of Water Resources 6,086  3,018 18,366 5.8% 13.3% 19.2% 3,519 
Dept of Youth Authority 6,581  2,969 19,540 6.8% 14.6% 21.4% 4,187 
Employment Development Dept 14,332  3,700 53,026 6.8% 16.4% 23.2% 12,321 
Franchise Tax Board 9,729  2,904 28,257 6.5% 13.6% 20.0% 5,660 
State Compensation Insurance Fund 15,498  3,262 50,560 7.2% 16.9% 24.1% 12,189 
Other Agencies 102,509  3,226 330,738 5.7% 15.0% 20.7% 68,566 
  a. Uncomplicated hypertension and/or diabetes 
  b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
To aid in determining the desirability of using workplace 
prevention interventions in these agencies and 
departments, we have also made these calculations for 
employees separately from their dependents, shown in 
tables 5b and 5c. For employees (table 5b), the average 
share of total spending attributable to preventable illness 
statewide is 28.4%. The departments with the highest 
shares for employees are the Departments of 
Developmental Services (37.4%), Transportation 
(32.1%), and Corrections (31.8%). The departments with 
the lowest shares are the Franchise Tax Board (22.7%), 
the Department of Health Care Services (24.0%), and 
the Department of Public Health (24.1%). 
 
For dependents (table 5c), the average share 
attributable to preventable disease is 16.8%, smaller 
than the 28.4% for employees. Rankings of departments 
also show somewhat different patterns. The department 
where dependents have the highest share of spending 
attributable to preventable causes is the Department of 
Health Care Services (22.3%), which has one of the 
lowest shares for employees. The Cal State System 
(22.1%) and the State Compensation Insurance Fund 
(21.3%) also have relatively high shares for dependents. 
The departments with the lowest shares for dependents 
are the Department of California Highway Patrol 
(11.1%), the Department of Forestry and Fire Protection 
(11.3%), and the Departments of Justice and Water 
Resources (13.4% each).  
attributable to preventable illness, excluding counties 
with less than $1 million in total CalPERS expenditures, 
ranged from 14.2 percent in Placer to 31.5 percent in 
Madera. The five counties with the largest proportions 
were Madera (31.5%), Los Angeles (30.8%), Tulare 
(30.4%), Imperial (30.4%), and Merced (30.0%). 
Counties with the lowest proportions were Placer 
(14.2%), Siskiyou (15.2%), Yuba (15.2%), Yolo (15.9%), 
and Sacramento (16.9%). 
 
Department/Agency 
Table 5a displays these calculations across the 19 
largest agencies/departments covered by CalPERS. The 
three departments with the largest shares of total 
expenditures for the selected preventable diseases, 
counting both employees and dependents, are the 
Department of Developmental Services (27.3%), the 
California State University system (26.1%), and the 
Department of Mental Health (25.5%). The three 
departments with highest total expenditures on 
preventable disease are the Department of Corrections 
($83.0 million), the California State University system 
($54.1 million), and the Department of Transportation 
($33.7 million). The departments with the lowest 
percentage of expenditures on these illnesses are the 
California Highway Patrol (16.4%), the Department of 
Forestry and Fire Protection (16.7%), the Department of 
Justice (19.1%), and the Department of Water 
Resources (19.2%). 
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Table 5c. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
for Largest Departments and Agencies, 2008 (Dependents Only) 
Department / Agency 
Number of 
Persons 
Covered 
Average 
Spending 
per Person 
($) 
Total 
CalPERS 
Payments 
($000) 
Share Attributable to  
Preventable Diseases Preventable 
Costs 
($000) Cluster Ia Cluster IIb Total 
Total (Dependents) 331,312  2,507 830,469 4.1% 12.6% 16.8% 139,197 
Board of Equalization 4,253  2,272 9,663 4.9% 10.7% 15.6% 1,507 
California State University System 41,794  2,241 93,667 4.9% 17.2% 22.1% 20,738 
Dept of California Highway Patrol 20,050  2,619 52,509 2.1% 9.0% 11.1% 5,846 
Dept of Corrections 90,197  2,338 210,881 3.8% 11.9% 15.7% 33,172 
Dept of Developmental Services 6,814  2,895 19,730 4.7% 14.1% 18.7% 3,697 
Dept of Forestry and Fire Protection 8,716  2,735 23,837 2.5% 8.8% 11.3% 2,704 
Dept of General Services 3,639  2,611 9,503 3.7% 13.6% 17.3% 1,647 
Dept of Health Care Services 2,929  2,840 8,320 5.1% 17.2% 22.3% 1,853 
Dept of Justice 5,423  2,671 14,486 3.1% 10.3% 13.4% 1,941 
Dept of Mental Health 12,193  2,462 30,022 5.0% 15.1% 20.2% 6,050 
Dept of Motor Vehicles 9,962  2,471 24,617 4.7% 12.5% 17.2% 4,235 
Dept of Public Health 2,975  3,058 9,098 4.5% 12.2% 16.6% 1,515 
Dept of Social Services 4,083  3,209 13,101 4.4% 10.9% 15.3% 2,007 
Dept of Transportation 30,717  2,435 74,799 4.4% 11.8% 16.2% 12,112 
Dept of Water Resources 3,709  2,853 10,580 3.8% 9.5% 13.4% 1,417 
Dept of Youth Authority 4,076  2,398 9,772 4.2% 11.3% 15.5% 1,513 
Employment Development Dept 7,930  2,820 22,366 5.0% 14.2% 19.2% 4,300 
Franchise Tax Board 5,586  2,237 12,497 5.2% 11.5% 16.7% 2,085 
State Compensation Insurance Fund 8,848  2,518 22,279 5.6% 15.7% 21.3% 4,746 
Other Agencies 57,418  2,765 158,742 4.1% 12.4% 16.5% 26,113 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
Table 5b. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
for Largest Departments and Agencies 2008 (Employees Only) 
Department / Agency 
Number of 
Persons 
Covered 
Average 
Spending 
per Person 
($) 
Total 
CalPERS 
Payments 
($000) 
Share Attributable to  
Preventable Diseases Preventable 
Costs 
($000) Cluster Ia Cluster IIb Total 
Total (Employees) 224,465  3,500 785,635 8.9% 19.5% 28.4% 222,851 
Board of Equalization 3,182  3,518 11,194 8.3% 16.1% 24.4% 2,732 
California State University System 34,105  3,321 113,272 8.2% 21.2% 29.4% 33,331 
Dept of California Highway Patrol 9,989  2,417 24,146 8.7% 19.2% 27.9% 6,728 
Dept of Corrections 49,614  3,155 156,539 10.9% 20.9% 31.8% 49,778 
Dept of Developmental Services 4,453  3,733 16,621 11.5% 25.9% 37.4% 6,212 
Dept of Forestry and Fire Protection 6,358  1,681 10,688 9.4% 19.1% 28.5% 3,045 
Dept of General Services 2,726  3,364 9,171 9.4% 19.7% 29.1% 2,671 
Dept of Health Care Services 2,509  4,423 11,097 7.2% 16.8% 24.0% 2,658 
Dept of Justice 4,068  3,813 15,510 7.0% 17.4% 24.4% 3,780 
Dept of Mental Health 8,704  3,763 32,757 10.3% 20.2% 30.5% 9,979 
Dept of Motor Vehicles 7,093  4,121 29,229 9.9% 17.3% 27.1% 7,929 
Dept of Public Health 2,549  4,442 11,324 6.7% 17.4% 24.1% 2,733 
Dept of Social Services 3,272  3,773 12,344 8.7% 18.6% 27.3% 3,375 
Dept of Transportation 18,675  3,614 67,491 10.0% 22.0% 32.1% 21,631 
Dept of Water Resources 2,377  3,275 7,785 8.5% 18.5% 27.0% 2,101 
Dept of Youth Authority 2,505  3,899 9,767 9.4% 18.0% 27.4% 2,674 
Employment Development Dept 6,402  4,789 30,660 8.2% 18.0% 26.2% 8,021 
Franchise Tax Board 4,143  3,804 15,760 7.5% 15.2% 22.7% 3,575 
State Compensation Insurance Fund 6,650  4,253 28,282 8.4% 17.9% 26.3% 7,444 
Other Agencies 45,091  3,814 171,996 7.3% 17.4% 24.7% 42,453 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
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Health Plan 
Finally, table 6 disaggregates expenditures across the 
nine health plans available to employees within 
CalPERS28 in 2008. There may be opportunities for 
individual plans within the CalPERS system to increase 
member participation in prevention programs, as 
UnitedHealth has done by reimbursing providers of 
lifestyle coaching to improve diet and increase physical 
activity to reduce type 2 diabetes among their members. 
Therefore, we identify plans with the most to gain from 
supporting members’ efforts to improve their health. 
Kaiser, the largest plan offered by CalPERS in terms of 
total payments, has the lowest share of expenditures 
going to preventable illness. Thus, it is only the third 
largest in terms of excess dollars spent on members 
with preventable illness ($78.8 million). Blue Shield 
Access+ has the highest expenditures ($107.5 million) 
on preventable illness. The plan with the highest 
proportion spent on these illnesses is PERSCare 
(36.7%), followed by PERS Choice (29.5%). 
 
 
Discussion 
This analysis provides parameters that could be useful 
to CalPERS in setting priorities and targeting initiatives 
to improve its members’ health while restraining medical 
care cost growth. Our excess spending estimates 
measure the potential benefits that could accrue to 
CalPERS from reduced medical care costs. They 
suggest that even a 1 percent reduction among State 
Active members in the prevalence of the common 
conditions we include in our analysis ultimately could 
save $3.6 million per year. The literature suggests that 
actual reductions of 5 percent to 15 percent are 
feasible,29 depending on how well-designed and targeted 
interventions are, indicating potential savings of $18 
million to $54 million annually.  
 
Our estimates are conservative because they do not 
include other diseases that may be affected by 
interventions to improve diet, increase exercise, and 
reduce smoking, and we do not capture medical costs 
associated with “predisease,” or reduced severity of the 
conditions we include. Interventions available to the 
whole CalPERS population, or even to those at high risk 
for disease onset, could affect these other costs, as well 
as those associated with diagnosed disease.  
 
The estimates also do not include any savings from 
productivity gains in a healthier workforce. Other 
research suggests that other benefits, such as improved 
productivity at work and reduced absenteeism costs, 
could be nearly as large, as noted above. These benefits 
would largely accrue to state government and other 
CalPERS employers. 
 
Finally, these estimates are also conservative because 
they are limited to current employees and their 
dependents and exclude retirees. Even if interventions 
are targeted only at active employees, those receiving 
the intervention who are close to retirement will likely 
have lower rates of health spending in retirement. While 
we do not have direct evidence in these data on the 
health of CalPERS retirees compared to workers at 
similar ages, we can make informed speculation as to 
the size of this impact. Higher per capita spending and 
the larger share of spending on preventable disease at 
older ages (table 2) suggest that savings from 
prevention efforts among retirees could be substantial 
and that prevention activities for active employees have 
the potential to reduce the cost of retiree health care in 
the long run.  
 
It is beyond the scope of this report to identify which 
interventions might be most appropriate for the various 
CalPERS populations. Different interventions have 
different costs and benefits. The Community Preventive 
Services Task Force web site has a carefully selected 
list of effective interventions.30  In addition, the reviews 
cited in the introduction to this report provide analysis of 
programs and extensive bibliographies to help guide 
program decisions.31  The most effective interventions 
are those that are carefully tailored to the target 
population. The breakdowns of the CalPERS population 
Table 6. CalPERS State Active Health Expenditures Attributable to Chronic Diseases Targetable by Lifestyle Interventions,  
by Health Plan, 2008 
Health Plan 
Number of 
Persons 
Covered 
Average 
Spending per 
Person ($) 
Total 
CalPERS Pay-
ments ($000) 
Share Attributable to  
Preventable Diseases Preventable 
Costs 
($000) Cluster Ia Cluster IIb Total 
Total 555,777  2,908 1,616,103 6.5% 15.9% 22.4% 362,047 
Blue Shield Access+ 129,955  3,311 430,292 6.9% 18.1% 25.0% 107,541 
Blue Shield NetValue 65,875  3,141 206,915 7.2% 18.2% 25.4% 52,600 
CAHP 20,789  2,376 49,395 3.6% 12.9% 16.5% 8,128 
CCPOA 32,616  2,000 65,243 7.6% 15.5% 23.2% 15,128 
Kaiser 209,416  2,528 529,386 5.6% 9.3% 14.9% 78,787 
PERS Choice 90,934  3,353 304,888 7.0% 22.4% 29.5% 89,843 
PERS Select 2,521  2,468 6,222 7.0% 17.4% 24.4% 1,520 
PERSCare 3,192  7,050 22,503 6.6% 30.0% 36.7% 8,252 
PORAC 454  2,768 1,257 4.2% 15.4% 19.6% 247 
a. Uncomplicated hypertension and/or diabetes 
b. Heart disease, cerebrovascular disease, or renal disease, with or without hypertension or diabetes 
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by demographics, geography, health plan, and agency/
department provide ways for CalPERS to make 
decisions about programs that will best suit the target 
populations.  
 
The populations with the highest share of spending 
related to preventable conditions have the potential to 
yield the greatest return on investment in prevention. 
However, populations with low shares of spending on 
preventable conditions may also provide valuable 
information about prevention by shedding light on what 
works. For example, health plans or employers with low 
shares of spending on preventable conditions may 
already have in place wellness promotion benefits or 
workplace programs that support employees’ health. 
CalPERS members in counties with low shares may 
have greater access to fitness opportunities or 
recreation activities. By identifying such characteristics, 
CalPERS may better understand what might benefit 
other health plans, employers, or geographic areas. In 
this sense, this analysis provides a starting point for 
CalPERS as it seeks to understand and promote ways 
to improve the health of its members and so help limit 
the growth of medical care costs.  
 
The rates of effectiveness demonstrated by the YMCA 
implementation of the Diabetes Prevention Program are 
consistent with prevalence reductions of 15%. 
http://www.thecommunityguide.org/worksite/index.html  
See especially Baicker et al. 2010 (footnote 16) and 
Goetzel et al., 2008 (footnote 18).  
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